References
- Lemon SM. Type A viral hepatitis: new developments in an old disease. N Engl J Med 1985: 313(17): 1059–67
- Krugman S. Effect of human immune serum globulin on infectivity of hepatitis A virus. J Infect Dis 1976: 134(1): 70–4
- Michel ML, Tiollais P. Structure and expression of the hepatitis B virus genome. Hepatology 1987: 7(1): 61–3S
- Shiels MT, Taswell HF, Czaja AJ, et al. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 1987: 93(4): 675–80
- Seeff LB, Koff RS. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 1986: 6(1): 11–22
- Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981: 2(8256): 1129–33
- Bryan JP, Sjogren M, Iqbal M, et al. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines. J Infect Dis 1990: 162(4): 789–93
- Lam KC, Lai CL, Ng RP, et al. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981: 304(7): 380–6
- Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990: 323(5): 295–301
- Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis 1986: 6(1): 67–81
- Alter MJ, Gerety RJ, Smallwood LA, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban US population. J Infect Dis 1982: 145(6): 886–93
- Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983: 85(2): 439–62
- Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989: 244(4902): 359–62
- Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989: 244(4902): 362–4
- Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989: 321(22): 1494–500
- Hsu HH, Gonzalez M, Fuong S, et al. Hepatitis C virus antibody on low-risk blood donors: implications for donor counselling. (Abstr) Gastroenterology 1991: 100(5: 2): A753
- Kuroki T, Nishiguchi S, Ueda T, et al. False-positive detection of hepatitis C (HCV) virus antibody (AB) in the absence of HCV RNA in autoimmune hepatitis. (Abstr) Gastroenterology 1991: 100(5: 2): A763
- Nishiguchi S, Kuroki T, Takeda T, et al. Detection of hepatitis C virus (HCV) antibodies (AB) and HCV RNA in patients with alcoholic liver disease. (Abstr) Gastroenterology 1991: 100(5: 2): A781
- Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfe: a multicenter randomized, controlled trial. N Engl J Med 1989: 321(22): 1501–6
- Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfe therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989: 321(22): 1506–10
- Jacobson IM, Dienstag JL, Werner BG, et al. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology 1985: 5(2): 188–91
- Gust ID, Purcell RH. Report of a workshop: waterborne non-A, non-B hepatitis. J Infect Dis 1987: 156(4): 630–5